Navigation Links
Cancer Vaccines: From First-in-Class to Best-in-Class?
Date:4/9/2013

0: responsif's Included Cancer Vaccine Drugs and Competitive Fall-Out 915
Table 221: Sanofi's Included Cancer Vaccine Drugs and Competitive Fall-Out 918
Table 222: Sarepta Therapeutics' Included Cancer Vaccine Drugs and Competitive Fall-Out 922
Table 223: Scancell's Included Cancer Vaccine Drugs and Competitive Fall-Out 926
Table 224: Shionogi's Included Cancer Vaccine Drugs and Competitive Fall-Out 929
Table 225: TapImmune's Included Cancer Vaccine Drugs and Competitive Fall-Out 932
Table 226: Therion Biologics' Included Cancer Vaccine Drugs and Competitive Fall-Out 936
Table 227: Transgene's Included Cancer Vaccine Drugs and Competitive Fall-Out 943
Table 228: United Biomedical's Included Cancer Vaccine Drugs and Competitive Fall-Out 947
Table 229: Vaccinex's Included Cancer Vaccine Drugs and Competitive Fall-Out 950
Table 230: Vaxil BioTherapeutics' Included Cancer Vaccine Drugs and Competitive Fall-Out 955
Table 231: Vaximm's Included Cancer Vaccine Drugs and Competitive Fall-Out 959
Table 232: Vaxon Biotech's Included Cancer Vaccine Drugs and Competitive Fall-Out 963
Table 233: Vectura's Included Cancer Vaccine Drugs and Competitive Fall-Out 967
Table 234: Vical's Included Cancer Vaccine Drugs and Competitive Fall-Out 971
Table 235: Viragen's Included Cancer Vaccine Drugs and Competitive Fall-Out 977
Table 236: Virionics' Included Cancer Vaccine Drugs and Competitive Fall-Out 980
Table 237: ViroMed's Included Cancer Vaccine Drugs and Competitive Fall-Out 984
Table 238: Zensun's Included Cancer Vaccine Drugs and Competitive Fall-Out 988
Table 239: Zydus Cadila's Included Cancer Vaccine Drugs and Competitive Fall-Out 992

To order this report:
Drug_and_Medication Industry:

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
2. Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting
3. Take the Skyhook Challenge and Help Beat Blood Cancer
4. Merrimack Pharmaceuticals Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
5. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
6. Penn Medicines New Center For Personalized Diagnostics Unlocks Cancers Secrets
7. Cerulean Pharma to Present Data on CRLX101s HIF-1a Inhibition at the American Association for Cancer Research Annual Meeting
8. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
9. NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
10. National Cancer Organizations Issue Joint Statement On Devastating Impact Of Sequestration
11. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , August 3, 2015 ... announced today that it has acquired ... Inc. for $300 million. With the acquisition, Shire ... drops combining 0.6% povidone iodine (PVP-I) and 0.1% ... treatment of infectious conjunctivitis, an ocular surface condition ...
(Date:7/31/2015)... CHAPEL HILL, N.C. , July 31, 2015 ... to product success in the biopharmaceutical market. Patients ... the process of selecting and switching therapies. This ... and is pushing marketers, efforts toward patient-focused marketing. ... to patient engagement, marketers have learned it,s important ...
(Date:7/31/2015)... 31, 2015 RnRMarketResearch.com adds ... research report that provides an overview of syringes ... sourced from in-house databases, secondary and primary research. ... market products pipeline spread across 124 pages, talking ... tables and 5 figures is now available at ...
Breaking Medicine Technology:Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 2Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 3Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 5Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 6Consumers Forcing Pharmaceutical Industry to Shift its Marketing Focus from Products to Patients 2Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5
... Calif., Jan. 4, 2011 Intarcia Therapeutics, Inc. today ... will present at the 29th Annual JP Morgan Healthcare ... 2011 at the Westin St. Francis Hotel in San ... About Intarcia Intarcia Therapeutics, ...
... Pa., Jan. 4, 2011 Owner and medical director of ... her practice and is now offering Pixel Perfect™ ... CO2 laser from Alma Lasers. "I,m very ... Cirillo-Hyland said. "As a long time provider of aesthetic laser ...
Cached Medicine Technology:Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference 2Philadelphia's Victoria A. Cirillo-Hyland, M.D. Adds Alma Lasers' Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to Patients 2
(Date:8/3/2015)... ... 03, 2015 , ... Illinois Health & Science (IHS) has completed the purchase ... includes all of IBAM NA’s cyclotron sites and research and development facilities. ... business, as well as a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, ...
(Date:8/3/2015)... ... August 03, 2015 , ... Hub ... that Joe Williams has joined its growing California employee benefits division. Mr. ... model to his clients. Mr. Williams will be joining the newly integrated Northern ...
(Date:8/3/2015)... ... August 03, 2015 , ... Cambia Health Solutions has promoted ... the company’s Medicare and Federal Employee Programs (FEP) lines of business. , ... for members. In this role, Scott is responsible for overseeing the growth, finance ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... provider of medical information, risk management and investigative services, has introduced a ... toward focused, expert information solutions that improve business outcomes for its customers. ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Did you ... or Orange County looking for exceptional and affordable home care options which A-1 Home ... are just a few of the credentials A-1 Home Care Agency is ...
Breaking Medicine News(10 mins):Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 3
... bird flu in northwestern Germany has been steadily increasing over ... 2 of the 103 cases were identified outside the Baltic ... have been involved in collection of carcasses. ,Recently, ... deadly virus. The Institute for Animal Health in Riems had ...
... might be able to reduce the harmful effects caused to ... reserachers at the Cornell// University. Foetal Alcohol Syndrome (FAS) results ... known cure for it. ,The reserachers say that ... ill effects of this particular syndrome. The researchers arrived at ...
... laid the foundation stone to construct a world-class cancer hospital ... come up at Rajarhat,// at the cost of Rs. 1.2 ... Centre (TMC) would come up on a 10-acre plot, West ... Tata said, after laying the foundation stone for the project ...
... than famous, is now going to face some competition. Private ... Canada, having garnered enough support from the several provinces in ... the Quebec government, which intended to remove the ban on ... offered to chip in and pick up costs for such ...
... which pertains to its French fries! Going by stats at ... use of wheat and milk as flavoring ingredients in French ... might trigger allergy in some individuals. ,Earlier, McDonald's also ... serving of fries is higher than previously estimated. ,The ...
... Kingdom: Pop Star Kelly, apart from lending her voice to ... cause of Breast cancer, with the authentic voice of personal ... Fund raising initiative in Staffordshire, England, Kelly, one of the ... support to the cause. , The Breast Cancer ...
Cached Medicine News:
Extremely fine straight....
Curved delicate 5 mm blades....
Micro dressing forceps....
... The Leica M520 OH3 is ... best optical performance available on ... and unique stand. The Leica ... has the greatest range of ...
Medicine Products: